相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Temozolomide Versus Procarbazine, Lomustine, and Vincristine in Recurrent High-Grade Glioma
Michael Brada et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Phase III Study of Enzastaurin Compared With Lomustine in the Treatment of Recurrent Intracranial Glioblastoma
Wolfgang Wick et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Hypofractionated Stereotactic Radiation Therapy: An Effective Therapy for Recurrent High-Grade Gliomas
Shannon E. Fogh et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Phase II Trial of Continuous Dose-Intense Temozolomide in Recurrent Malignant Glioma: RESCUE Study
James R. Perry et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
Patrick Y. Wen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Glioblastoma multiforme: a review of where we have been and where we are going
Cory Adamson et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Bendamustine: Rebirth of an Old Drug
Bruce D. Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Rechallenge with temozolomide in patients with recurrent gliomas
Antje Wick et al.
JOURNAL OF NEUROLOGY (2009)
Bendamustine (Treanda) displays a distinct pattern of cytotoxicity and unique mechanistic features compared with other alkylating agents
Lorenzo M. Leoni et al.
CLINICAL CANCER RESEARCH (2008)
Glioblastoma multiforme: an emerging paradigm of anti-VEGF therapy
David A. Reardon et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2008)
Bendamustine in patients with rituximab-refractory indolent and transformed non-Hodgkin's lymphoma: Results from a phase II multicenter, single-agent study
Jonathan W. Friedberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme
David A. Reardon et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Radiochemotherapy with temozolomide as re-irradiation using high precision fractionated stereotactic radiotherapy (FSRT) in patients with recurrent gliomas
Stephanie E. Combs et al.
JOURNAL OF NEURO-ONCOLOGY (2008)
Bendamustine
Michael J. Keating et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Malignant gliomas in adults
Patrick Y. Wen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Antiangiogenic agents for the treatment of glioblastoma
Elizabeth R. Gerstner et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
A phase I trial of sorafenib (BAY 43-9006) for patients with recurrent or progressive malignant glioma (NABTT 0401)
L. B. Nabors et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Iatrogenic immunosuppression in patients with newly diagnosed high-grade gliomas
S. A. Grossman et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Prognostic factors for survival in adult patients with recurrent glioma enrolled onto the new approaches to brain tumor therapy CNS consortium phase I and II clinical trials
Kathryn A. Carson et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Phase I and correlative biology study of cilengitide in patients with recurrent malignant glioma
L. Burt Nabors et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme
Karla V. Ballman et al.
NEURO-ONCOLOGY (2007)
Recurrent glioblastoma multiforme: advances in treatment and promising drug candidates
Lijo Simpson et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2006)
PCV chemotherapy for recurrent glioblastoma
F Schmidt et al.
NEUROLOGY (2006)
Phase-I/II study to evaluate dose limiting toxicity, maximum tolerated dose, and tolerability of bendamustine HCl in pre-treated patients with B-chronic lymphocytic leukaemia (Binet stages B and C) requiring therapy
T Lissitchkov et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2006)
Salvage chemotherapy with cyclophosphamide for recurrent, temozolomide-refractory glioblastoma multiforme
MC Chamberlain et al.
CANCER (2004)
13-cis-retinoic acid in the treatment of recurrent glioblastoma multiforme
SJ See et al.
NEURO-ONCOLOGY (2004)
Phase II evaluation of temozolomide and 13-cis-retinoic acid for the treatment of recurrent and progressive malignant glioma:: A North American Brain Tumor Consortium study
KA Jaeckle et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Regression of brain metastases from breast carcinoma after chemotherapy with bendamustine
K Zulkowski et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2002)
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse
WKA Yung et al.
BRITISH JOURNAL OF CANCER (2000)
分享论文
